RNA modification in cardiovascular disease: implications for therapeutic interventions

Cardiovascular disease(CVD)is the leading cause of death in the world,with a high incidence and a youth-oriented tendency.RNA modification is ubiquitous and indispensable in cell,maintaining cell homeostasis and function by dynamically regulating gene expression.Accumulating evidence has revealed the role of aberrant gene expression in CVD caused by dysregulated RNA modification.In this review,we focus on nine common RNA modifications:N^(6)-methyladenosine(m^(6)A),N^(1)-methyladenosine(m^(1)A),5-methylcytosine(m^(5)C),N^(7)-methylguanosine(m^(7)G),N^(4)-acetylcytosine(ac^(4)C),pseudouridine(Ψ),uridylation,adenosine-to-inosine(A-to-I)RNA editing,and modifications of U34 on tRNA wobble.We summarize the key regulators of RNA modification and their effects on gene expression,such as RNA splicing,maturation,transport,stability,and translation.Then,based on the classification of CVD,the mechanisms by which the disease occurs and progresses through RNA modifications are discussed.Potential therapeutic strategies,such as gene therapy,are reviewed based on these mechanisms.Herein,some of the CVD(such as stroke and peripheral vascular disease)are not included due to the limited availability of literature.Finally,the prospective applications and challenges of RNA modification in CVD are discussed for the purpose of facilitating clinical translation.Moreover,we look forward to more studies exploring the mechanisms and roles of RNA modification in CVD in the future,as there are substantial uncultivated areas to be explored.